|Re: A Special Meeting of the shareholders of Tonix Pharmaceuticals Holding Corp. ...|
This is funny, company wants to increase shares from 15,000,000 to 150,000,000. This company wants to dilute the shares again and again.
market doesn't believe company would release positive P3 data in Q1, 2020. It has failed twice during the past.
Looks like it will drop to below $1 very soon.....we'll see.
| Reply to hunter1 - Msg #755 - 12/02/2019 17:35|
A Special Meeting of the shareholders of Tonix Pharmaceuticals Holding Corp. (the “Company” or “Tonix”) will be held on January 16, 2020, at 11:00 a.m. local time at the offices of Lowenstein Sandler LLP at 1251 Avenue of the Americas, New York, New York 10020 for the purposes of:
To approve an amendment to the Company’s Articles of Incorporation, as amended, to increase the Company’s authorized shares of common stock from 15,000,000 to 150,000,000;
To approve the Tonix Pharmaceuticals Holding Corp. 2020 Stock Incentive Plan;
To approve, for purposes of complying with applicable NASDAQ Listing Rules, the potential issuance and sale of 20% or more of the Company’s common stock pursuant to the Company’s purchase agreement with Lincoln Park Capital Fund LLC pursuant to which Lincoln Park Capital Fund LLC has agreed to purchase from us, from time to time, up to $15,000,000 of our common stock; and
To act on such other matters as may properly come before the meeting or any adjournment thereof.
Pursuant to the Third Amended and Restated Bylaws of the Company, no business is proper for consideration, or may be acted upon, at the Special Meeting, except as set forth in this Notice of Special Meeting of Shareholders.
Only shareholders of record at the close of business on November 22, 2019, will be entitled to attend and vote at the meeting. A list of all shareholders entitled to vote at the Special Meeting, arranged in alphabetical order and showing the address of and number of shares held by each shareholder, will be available at the principal office of the Company during usual business hours, for examination by any shareholder for any purpose germane to the Special Meeting for 10 days prior to the date thereof. The proxy materials will be furnished to shareholders on or about December , 2019.
BY ORDER OF THE BOARD OF DIRECTORS